<< Back To Products
BioScience
Renal
Medication Delivery
Baxter’s vast experience in plasma fractionation has resulted in reliable and innovative therapeutics developed from human serum albumin to support these patients.
Baxter Vaccines
Our long-standing commitment to provide high-quality therapies for people with hemophilia has led to innovations including monoclonal antibody purification and heat treatment processes, introduction of the first recombinant Factor VIII therapy, and most recently, of the first plasma/albumin-free method recombinant Factor VIII therapy.
Our mission is to improve surgical practice by the development and use of biomaterials for hard and soft tissue repair, and the complex challenges of surgery.
Print this page 